Ruilian New Materials: Several photoresist monomer materials have entered mass production.
February 5 that Ruilian New Materials stated in response to investor inquiries on an interactive platform that the company currently has a variety of semiconductor photoresist monomer materials in reserve, several of which are already in mass production, some are in the customer verification stage, and some have entered the downstream verification stage.
Ruilian New Materials accumulated experience in synthesis and purification, capabilities in metal ion analysis, detection, and removal, advantages in pilot-scale production, and a strong reputation in the Japanese market, the company began developing photoresist materials, including semiconductor photoresist monomers and film material intermediates, in 2015. Focusing on high-end photoresist materials, its main products currently include semiconductor photoresist monomers, TFT planarization layer photoresists, film material intermediates, and polyimide monomers. The film material intermediates primarily serve as optical film materials for display panels, while the photoresist materials include display photoresists and semiconductor photoresist monomers. Semiconductor photoresist monomers mainly consist of ArF, KrF, and EUV photoresist monomers; display photoresists primarily serve as TFT planarization layer photoresists. The photoresist market has high barriers to entry and long customer validation cycles. The company has already developed multiple photoresist materials, experiencing rapid business growth, and its products are exported to well-known companies in countries such as South Korea and Japan.
Xi'an Ruilian New Materials Co., Ltd., established in 1999, is jointly owned by investment institutions such as Zhuoshi Partnership and Guofu Investment, as well as the company's senior and middle-level management. The company is a high-tech enterprise specializing in the research, development, production, and sales of specialized organic new materials. Its main products include monomeric liquid crystals, OLED materials, and innovative drug intermediates, used in the production of OLED terminal materials, mixed liquid crystals, and active pharmaceutical ingredients. The end-use applications of its products include OLED displays, TFT-LCD displays, and pharmaceutical preparations.
